Navigation Links
Yongye Biotechnology Announces Record Third Quarter Results
Date:11/13/2008

and Subsidiaries Yongye

September 30, 2008 December 31, 2007

(Unaudited)

CURRENT ASSETS

Cash and Cash Equivalents $6,847,558 $376,002

Accounts Receivable 20,678,867 1,630,609

Inventories 2,060,532 9,851,788

Advance Payments 273,722 --

Due from Affiliates 954,431 978,384

Other Receivables 1,247,929 27,038

Total Current Assets 32,063,039 12,863,821

PROPERTY AND EQUIPMENT, NET 3,386,463 2,486,487

INTANGIBLE ASSETS, NET 114,817 3,665,584

LONG-TERM INVESTMENTS -- 4,115,764

TOTAL ASSETS $35,564,319 $23,131,656

CURRENT LIABILITIES

Accounts Payable and Accrued

Expenses 1,503,005 1,271,852

Short-term Bank Loan -- 5,484,000

Due to Shareholders -- 2,507,371

Due to Related Parties 1,646,282

Tax Payables 414,997 893,892

Other Payables 85,986 50,916

Total Current Liabilities 3,650,270 10,208,031

LONG-TERM LIABILITY 204,962 12,153

Minority Interest 1,192,426 --

STOCKHOLDERS' EQUITY

Capital Stock: 26,760,258 shares

authorized and issued par value

$.001 as of September 30, 2008 26,
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
2. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
3. Yongye Biotechnology International Raises $9.4 Million in Private Placement
4. Yongye Biotechnology International Announces Second Quarter Results
5. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
6. Yongye Biotechnology International Retains CCG Investor Relations
7. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
8. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
9. World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
10. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
11. InNexus Biotechnology Receives Patent Grants in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy & ... it has signed a letter of intent to ... developed and patented a nanotechnology-based development platform used ... that enable rapid on-site collection and testing to ... health issues in an immediate, non-invasive and cost-effective ...
(Date:12/22/2014)... 22, 2014 ITRA Global, one of ... of commercial real estate, has further expanded its global ... Perth and Brisbane, Western Australia, reports Mylinda Vick, CCIM, ... ITRA Global / ACORPP (Australian Corporate Property and ... company providing property services to a wide range of ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the ... Maroulis, Pharm.D. to the newly created position of Vice ... position, Dr. Maroulis will continue to manage the entire ... multi-site pharmacies as the company expands. Dr. Maroulis has ... he has served in many different capacities in the ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 19, 2014 ... biomaterial market will grow at a 12 percent compound ... a result of the aging population and the increasing ... Latin America will also spur demand ... results of dental implant and periodontal treatments. ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3
... now lost as heat during the production of ... silicon nanowires synthesized via a technique developed by ... Lawrence Berkeley National Laboratory (Berkeley Lab) and the ... potential applications of this technology include DOEs hydrogen ...
... NEW YORK, January 10 HealthCare Technologies,Ltd., (the ... dated,January 7, 2008 from the Staff of the ... Stock Market LLC, which indicated,that because the Staff ... Biofuels, Inc., which closed on December 31, 2007, ...
... Seven Summits Research issues,PriceWatch Alerts for key stocks., ... at, http://www.iotogo.com/s/011008B (Note: You may have ... [ENTER] key.), Today,s PriceWatch Alerts cover the following ... & Co., Inc. (NYSE: MER ), DryShips, Inc. ...
Cached Biology Technology:Feeling the heat 2Feeling the heat 3Feeling the heat 4HealthCare Technologies Ltd. (NASDAQ: HCTL) Announces Receipt of NASDAQ Delisting Notice 2Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI 2Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI 3
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... Ireland, the number of people surviving the disease in the ... year there are between 50-60 men and women who survive ... The survival rates in Northern Ireland for cancers including ... and its patients are benefiting from improved treatment outcomes by ...
... This release is available in German . According ... the Lily of the Valley scent known as Bourgeonal alters the calcium ... Valley phenomenon" also the title of a book about smelling ... swimming olfactory cells which follow a "scent trail" laid by the egg. ...
... the aid of light: this is made possible ... of neurobiological processes with unprecedented spatial and temporal ... light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin ... through an interdisciplinary approach. The researchers report on ...
Cached Biology News:More people surviving cancer in Northern Ireland 2The end of the 'Lily of the Valley phenomenon' in sperm research? 2The end of the 'Lily of the Valley phenomenon' in sperm research? 3Optogenetic tool elucidated 2
... Imaging Systems group announces the availability ... Imaging Systems, featuring high resolution cooled ... luminescence, radiographic and chromogenic imaging capability. ... and 10x optical zoom lens provides ...
... that oxidative stress is involved in atherosclerosis, ... is the condition in which an imbalance ... leading to the damage of a cell. ... is through several antioxidant systems4 that include ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential Neurological liabilities of compound...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
Biology Products: